EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CRVW

CRVW

CareView Communications Inc

Next earnings Aug 11, 2026

Avoid
$0.06
▲ +6.67%
$0.06▲ +255.56%
over 1Y
L $0.01EODHDH $0.07
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.7%
1W+15.9%
1M+18.2%
3M+95.7%
YTD+247.6%
1Y+228.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Fair value
Filings
Clean
Avoid
Conviction
Horizon
Medium (3–12mo)

Revenue grew 9.3% YoY; but unprofitable (net margin -35.5%).

Revenue (FY2025) $9.02M · FY2025

CareView Communications Inc shows $9.02M in FY2025 revenue (+9.3% YoY), a -35.5% net margin, and 7.4% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$7.80M$7.90M$9.68M$8.25M$9.02M
Gross profit—————
Operating income-$1.15M-$1.27M-$688K-$1.58M-$55.0K
Net income——-$3.95M-$4.70M-$3.20M
Diluted EPS-$0.07-$0.04-$0.01——
Net margin——-40.8%-57.0%-35.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$66.9M
EV / EBITDA604.6
EV / Sales7.4
EV / FCF84.0
P / FCF46.9
PEG (trailing)—
Earnings yield-8.6%
FCF yield2.1%

Quality & risk

ROIC (est.)—
Free cash flow$797K
Total debt$31.1M
Net cash-$29.6M
Altman Z-Score-73.97 distress
Piotroski F-Score5/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 10-Q Quarterly report2026-05-13
  2. 8-K Material agreement2026-04-02
  3. 10-K Annual report2026-03-30
  4. 8-K Material agreement2026-01-06
  5. 10-Q Quarterly report2025-11-13
  6. 8-K Material agreement2025-10-02
  7. 10-Q Quarterly report2025-08-13
  8. 8-K Material agreement2025-07-02
  9. 10-Q Quarterly report2025-05-15

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-05-13open ↗8-KPeriod ending 2026-03-302026-04-02open ↗10-KPeriod ending 2025-12-312026-03-30open ↗8-KPeriod ending 2025-12-312026-01-06open ↗10-QPeriod ending 2025-09-302025-11-13open ↗8-KPeriod ending 2025-09-302025-10-02open ↗10-QPeriod ending 2025-06-302025-08-13open ↗8-KPeriod ending 2025-06-302025-07-02open ↗10-QPeriod ending 2025-03-312025-05-15open ↗10-K/APeriod ending 2024-12-312025-04-15open ↗10-KPeriod ending 2024-12-312025-04-01open ↗8-KPeriod ending 2025-03-212025-03-25open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueC
GrowthA-
ProfitabilityF
Financial healthF
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
Revenue
$9.02M
+9.3% YoY
Net margin
-35.5%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$9.02M+9.3%
Net income-$3.20M+31.9%
Operating income-$55.0K+96.5%
Diluted EPS-$0.01+75.0%
Cash & equivalents$1.55M+103.7%
Total assets$4.64M+28.1%
Total liabilities$47.7M+8.2%
Stockholders' equity-$43.0M-6.4%
Op.: -0.6%L/E: -1.11x

Frequently asked

Is CareView Communications Inc (CRVW) a buy?
CRVW currently carries a Avoid rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 9.3% YoY; but unprofitable (net margin -35.5%).
What is CareView Communications Inc's quality score?
CRVW scores 42.35294117647059/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001377149, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 11:38:00 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2023-05-24
HealthCor Management, L.P.
Director
Acquired (C)86.5M @ $0.10$8.65M
2023-05-24
HealthCor Management, L.P.
Director
Acquired (C)93.5M @ $0.10$9.35M
2023-05-24
HealthCor Associates, LLC
Director
Acquired (C)86.5M @ $0.10$8.65M
2023-05-24
HealthCor Associates, LLC
Director
Acquired (C)93.5M @ $0.10$9.35M

Recent news

market news →
CoreWeave's 2025 -- The Year Its Growth Story Became ClearBullish
finance.yahoo.com· 2026-02-04
COREWEAVE, INC. (NASDAQ: CRWV) INVESTOR ALERT Investors With Large Losses in CoreWeave, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsBullish
globenewswire.com· 2026-01-13
Meta PT Cut to $720 as Analysts Flag Rising AI and Cloud CostsBullish
finance.yahoo.com· 2025-11-25
Stock market today: S&P 500, Nasdaq soar, lead Dow higher as Senate vote lifts hopes for end to US shutdownBullish
finance.yahoo.com· 2025-11-10
Nvidia CEO Jensen Huang Confirms A Major Investment In Elon Musk's XAIBullish
finance.yahoo.com· 2025-10-09
Tesla Surge, Alphabet's $3T Milestone Push Nasdaq to Record Highs Ahead of FedBullish
finance.yahoo.com· 2025-09-15

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score42 vs 67
Revenue growth9.3% vs 7.1%
Net margin-35.5% vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5